Prediction of long−term outcome after primary
... Of the enrolled 127 patients, two died due to malignant ventricular arrhythmias during the first 24 hours after admission. In 10 patients, the initial echocardiographic study was ineligible for interpretation. Finally, 115 patients were evaluated (Tables 1 and 2). The mean time from symptom onset to ...
... Of the enrolled 127 patients, two died due to malignant ventricular arrhythmias during the first 24 hours after admission. In 10 patients, the initial echocardiographic study was ineligible for interpretation. Finally, 115 patients were evaluated (Tables 1 and 2). The mean time from symptom onset to ...
A Call for Universal Definitions in Cardiovascular Disease
... These investigators used several meticulously standardized definitions of MI, including that suggested by the first task force for the revision of the definition. Their carefully done comparison involved 1851 patients with the after-discharge diagnoses of acute and old MI, unstable angina, coronary ...
... These investigators used several meticulously standardized definitions of MI, including that suggested by the first task force for the revision of the definition. Their carefully done comparison involved 1851 patients with the after-discharge diagnoses of acute and old MI, unstable angina, coronary ...
CHA2DS2VASc Score as a Predictor of
... Results: Four hundred sixty-eight patients without AF were enrolled with a mean follow-up of 12 ± 6 months. Age was 64.9 ± 11.3 years. The prevalence of HTN was 88.4%, diabetes 37.6%, heart failure 26.3%, and vascular disease 61.7%. Overall, CHA2 DS2 VASc score was 3.4 ± 1.4. There were 15 major adv ...
... Results: Four hundred sixty-eight patients without AF were enrolled with a mean follow-up of 12 ± 6 months. Age was 64.9 ± 11.3 years. The prevalence of HTN was 88.4%, diabetes 37.6%, heart failure 26.3%, and vascular disease 61.7%. Overall, CHA2 DS2 VASc score was 3.4 ± 1.4. There were 15 major adv ...
Sudden Death in the Young Athlete
... cardiac arrhythmias and morphological abnormalities that can closely resemble serious cardiovascular diseases such as hypertrophic, dilated, and arrhythmogenic right ventricular cardiomyopathies as well as sinus and complex ventricular dysrhythmias that may result in inappropriate disqualification o ...
... cardiac arrhythmias and morphological abnormalities that can closely resemble serious cardiovascular diseases such as hypertrophic, dilated, and arrhythmogenic right ventricular cardiomyopathies as well as sinus and complex ventricular dysrhythmias that may result in inappropriate disqualification o ...
Heart rate and atherosclerosis Jean-Claude Tardif *
... resulting from increased HR may be due to both mechanical and metabolic factors. Increased vascular wall stress may contribute to endothelial injury, potentially promoting the complex cascade of events leading to increased atherosclerosis. Experimental data also show that a reduction in HR can delay ...
... resulting from increased HR may be due to both mechanical and metabolic factors. Increased vascular wall stress may contribute to endothelial injury, potentially promoting the complex cascade of events leading to increased atherosclerosis. Experimental data also show that a reduction in HR can delay ...
Patients with interatrial communications
... a strong correlation between the size of PFO and the severity of neurological symptoms in patients with transient ischemic attacks. There is no standard approach to patients with PFO and ischemic stroke, regarding both pharmacological treatment and surgical/percutaneous correction. Although there ar ...
... a strong correlation between the size of PFO and the severity of neurological symptoms in patients with transient ischemic attacks. There is no standard approach to patients with PFO and ischemic stroke, regarding both pharmacological treatment and surgical/percutaneous correction. Although there ar ...
Cardiology Step 3 Review
... follow-up after ED visit for L sided chest pressure 2 weeks lasting 10-20 min in duration with no radiation. Escalation of symptoms 2 days prior to ED visit, SOB on exertion, and diaphoresis on onset of pressure. Transient 1.5 mm ST elevation anterior leads, no Q waves, and negative enzymes. BP 150/ ...
... follow-up after ED visit for L sided chest pressure 2 weeks lasting 10-20 min in duration with no radiation. Escalation of symptoms 2 days prior to ED visit, SOB on exertion, and diaphoresis on onset of pressure. Transient 1.5 mm ST elevation anterior leads, no Q waves, and negative enzymes. BP 150/ ...
Cardiovascular system
... Failures can result from an inability of the heart chambers to relax sufficiently during diastole. Can occur with left ventricular hypertrophy, myocardial fibrosis, deposition of amyloid or constrictive pericarditis. Causes: Ischemic heart disease Hypertension Aortic & mitral valve disease ...
... Failures can result from an inability of the heart chambers to relax sufficiently during diastole. Can occur with left ventricular hypertrophy, myocardial fibrosis, deposition of amyloid or constrictive pericarditis. Causes: Ischemic heart disease Hypertension Aortic & mitral valve disease ...
PDF
... Cardiac resynchronization therapy (CRT) can help improve left ventricular systolic function and symptoms of heart failure by restoring the normal AV and intraventricular conduction patterns and synchronous contractility2. According to current guidelines, CRT has class I indication in HF patients wit ...
... Cardiac resynchronization therapy (CRT) can help improve left ventricular systolic function and symptoms of heart failure by restoring the normal AV and intraventricular conduction patterns and synchronous contractility2. According to current guidelines, CRT has class I indication in HF patients wit ...
Cardiac 2010
... Medium to moderate holes will cause problems when the pressure in the right side of the heart decreases and blood will start to flow to the path of least resistance (from the left ventricle through the VSD to the right ventricle and into the lungs) This will generally lead to CHF ...
... Medium to moderate holes will cause problems when the pressure in the right side of the heart decreases and blood will start to flow to the path of least resistance (from the left ventricle through the VSD to the right ventricle and into the lungs) This will generally lead to CHF ...
Anthem™ RF
... NYHA Class II or III heart failure, the reduction of the symptoms of moderate to severe heart failure (NYHA Class III or IV) in those patients who remain symptomatic despite stable, optimal medical therapy, and have a left ventricular ejection fraction ≤ 35% and a prolonged QRS duration, implantatio ...
... NYHA Class II or III heart failure, the reduction of the symptoms of moderate to severe heart failure (NYHA Class III or IV) in those patients who remain symptomatic despite stable, optimal medical therapy, and have a left ventricular ejection fraction ≤ 35% and a prolonged QRS duration, implantatio ...
1 CARDIOLOGY FOR PRIMARY CARE Lois E Brenneman, MSN
... - NO T T RU E A RR HY TH MIA but physiologic response to decrease in left ventricular volume during inspiration. blood in right ventricle is pumped into large capacitance bed of lungs therefore return of blood from lungs to heart is decreased and left atrium and left ventricle becom e sm aller. - At ...
... - NO T T RU E A RR HY TH MIA but physiologic response to decrease in left ventricular volume during inspiration. blood in right ventricle is pumped into large capacitance bed of lungs therefore return of blood from lungs to heart is decreased and left atrium and left ventricle becom e sm aller. - At ...
Hamartoma of the Mitral Valve with Blood Cysts: A Rare Tumor
... posterior papillary muscle head, which could be an inflammatory reaction to the cyst. Valvular locations have not been described because the parasitic agent arrives from the blood stream, through the coronary circulation. In our case it could have developed from the papillary muscle circulation. In ...
... posterior papillary muscle head, which could be an inflammatory reaction to the cyst. Valvular locations have not been described because the parasitic agent arrives from the blood stream, through the coronary circulation. In our case it could have developed from the papillary muscle circulation. In ...
PDF
... 1. Page 1163, Figure 3A and 3B, Singh JP et al. Left ventricular lead position and clinical outcome in the multicenter automatic defibrillator implantation trial-cardiac resynchronization therapy (MADIT-CRT) trial. Circulation 2011;123:1159–1166. 2. Thebault C et al. Sites of left and right ventricu ...
... 1. Page 1163, Figure 3A and 3B, Singh JP et al. Left ventricular lead position and clinical outcome in the multicenter automatic defibrillator implantation trial-cardiac resynchronization therapy (MADIT-CRT) trial. Circulation 2011;123:1159–1166. 2. Thebault C et al. Sites of left and right ventricu ...
Galectin-3 and N-Terminal of Prohormone Brain Natriuretic
... the Chi2 test, and the Fisher exact test. The potential factors that may be associated with cardiovascular events was identified first by the univariate analysis, then multivariate logistic regression analyses were used to identify the predict factors. A calculated difference of P<0.05 was considere ...
... the Chi2 test, and the Fisher exact test. The potential factors that may be associated with cardiovascular events was identified first by the univariate analysis, then multivariate logistic regression analyses were used to identify the predict factors. A calculated difference of P<0.05 was considere ...
cryptococcosis ofthe heart - Heart
... outcome in untreated cases. No specific mention is made by Littman (1959) or Baker and Haugen (1955) of myocardial involvement in disseminated cryptococcosis. This was the dominant feature of the clinical picture in the case reported here, which presented with severe tachycardia and acute heart fail ...
... outcome in untreated cases. No specific mention is made by Littman (1959) or Baker and Haugen (1955) of myocardial involvement in disseminated cryptococcosis. This was the dominant feature of the clinical picture in the case reported here, which presented with severe tachycardia and acute heart fail ...
Early amiodarone pulmonary toxicity simulating heart failure
... He was discharged after nine days with a view to readmission for cardiac catheterisation and mitral valve surgery. He was re-admitted one week later with progressive dyspnoea on minimal exertion and at rest but without nocturnal dyspnoea. The pulse was 72 beats per minute and the blood pressure was ...
... He was discharged after nine days with a view to readmission for cardiac catheterisation and mitral valve surgery. He was re-admitted one week later with progressive dyspnoea on minimal exertion and at rest but without nocturnal dyspnoea. The pulse was 72 beats per minute and the blood pressure was ...
1439573491-2 Heart anatomy
... Pulmonary circulation supplied by right ventricle is a much low pressure system requiring less energy output by ventricle Systemic circulation supplied by left ventricle is a higher pressure system and thus requires more forceful ...
... Pulmonary circulation supplied by right ventricle is a much low pressure system requiring less energy output by ventricle Systemic circulation supplied by left ventricle is a higher pressure system and thus requires more forceful ...
Circulatory System
... • Bradycardia: Heart rate less than 60 bpm • Sinus arrhythmia: Heart rate varies 5% during respiratory cycle and up to 30% during deep respiration • Premature atrial contractions: Occasional shortened intervals between one contraction and succeeding, frequently occurs in healthy people ...
... • Bradycardia: Heart rate less than 60 bpm • Sinus arrhythmia: Heart rate varies 5% during respiratory cycle and up to 30% during deep respiration • Premature atrial contractions: Occasional shortened intervals between one contraction and succeeding, frequently occurs in healthy people ...
ECG - Wsimg.com
... Monitoring of three bipolar leads by recording the potential difference between each of three pairs of electrodes: lead I , lead II, lead III, or other modified chest leads. ADVANTAGE: -good enough to track the heart rate, - detect R waves for synchronized direct-current (DC) shock in cardioversion ...
... Monitoring of three bipolar leads by recording the potential difference between each of three pairs of electrodes: lead I , lead II, lead III, or other modified chest leads. ADVANTAGE: -good enough to track the heart rate, - detect R waves for synchronized direct-current (DC) shock in cardioversion ...
Powerpoint template for scientific posters
... of ICD or LVAD malfunction resulting from the interaction between the two devices. Furthermore, in the patients that had VAs requiring ICD therapy, the LVAD did not interfere with proper ICD function. Despite LVAD therapy, a significant number of patients in our series did experience VAs (16%) and w ...
... of ICD or LVAD malfunction resulting from the interaction between the two devices. Furthermore, in the patients that had VAs requiring ICD therapy, the LVAD did not interfere with proper ICD function. Despite LVAD therapy, a significant number of patients in our series did experience VAs (16%) and w ...
Activity 5.3.1: Key My Heart
... It is pretty much a sac that covers and protects the heart. It is left open because there is no particular benefit for either, except that when it is re-closed it may cause cardiac tamponade which could be dangerous. 2. Why are sutures put in the ascending aorta, superior vena cava, and the inferior ...
... It is pretty much a sac that covers and protects the heart. It is left open because there is no particular benefit for either, except that when it is re-closed it may cause cardiac tamponade which could be dangerous. 2. Why are sutures put in the ascending aorta, superior vena cava, and the inferior ...
Vertebral Heart Scale
... diagnostics, such as a VHS and measurement of blood pressure. As guidelines for the treatment of heart disease in veterinary medicine evolve, it will become increasingly important to accurately stage patients with these conditions to determine when medical treatment is indicated. VHS calculation can ...
... diagnostics, such as a VHS and measurement of blood pressure. As guidelines for the treatment of heart disease in veterinary medicine evolve, it will become increasingly important to accurately stage patients with these conditions to determine when medical treatment is indicated. VHS calculation can ...
Cardiac contractility modulation
Cardiac contractility modulation (CCM) is a treatment for patients with moderate to severe left ventricular systolic heart failure (NYHA class II–IV). The short- and long-term use of this therapy enhances both the strength of ventricular contraction and the heart’s pumping capacity. The CCM mechanism is based on stimulation of the cardiac muscle by non-excitatory electrical signals (NES). CCM treatment is delivered by a pacemaker-like device that applies the NES, adjusted to and synchronized with the electrical action in the cardiac cycle.In CCM therapy, electrical stimulation is applied to the cardiac muscle during the absolute refractory period. In this phase of the cardiac cycle, electrical signals cannot trigger new cardiac muscle contractions, hence this type of stimulation is known as a non-excitatory stimulation. However, the electrical CCM signals increase the influx of calcium ions into the cardiac muscle cells (cardiomyocytes). In contrast to other electrical stimulation treatments for heart failure, such as pacemaker therapy or implantable cardioverter defibrillators (ICD), CCM does not affect the cardiac rhythm directly. Rather, the aim is to enhance the heart’s natural contraction (the native cardiac contractility) sustainably over long periods of time. Furthermore, unlike most interventions that increase cardiac contractility, CCM is not associated with an unfavorable increase in oxygen demand by the heart (measured in terms of Myocardial Oxygen Consumption or MVO2). This may be explained by the beneficial effect CCM has in improving cardiac efficiency. A meta-analysis in 2014 and an overview of device-based treatment options in heart failure in 2013 concluded that CCM treatment is safe, that it is generally beneficial to patients and that CCM treatment increases the exercise tolerance (ET) and quality of life (QoL) of patients. Furthermore, preliminary long-term survival data shows that CCM is associated with lower long-term mortality in heart failure patients when compared with expected rates among similar patients not treated with CCM.